ABS Direct Equity Fund LLC Makes New Investment in Astera Labs, Inc. $ALAB

ABS Direct Equity Fund LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 2,400 shares of the company’s stock, valued at approximately $263,000.

A number of other hedge funds have also recently made changes to their positions in ALAB. Reflection Asset Management acquired a new position in Astera Labs during the 4th quarter valued at about $25,000. Smartleaf Asset Management LLC increased its holdings in Astera Labs by 422.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after purchasing an additional 152 shares in the last quarter. Towarzystwo Funduszy Inwestycyjnych PZU SA purchased a new stake in shares of Astera Labs in the fourth quarter worth approximately $33,000. Whipplewood Advisors LLC raised its stake in shares of Astera Labs by 15,950.0% in the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock worth $35,000 after purchasing an additional 319 shares during the last quarter. Finally, Assetmark Inc. lifted its holdings in shares of Astera Labs by 78.9% in the fourth quarter. Assetmark Inc. now owns 229 shares of the company’s stock valued at $38,000 after purchasing an additional 101 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $291.58 on Monday. The firm has a market cap of $49.98 billion, a PE ratio of 197.01, a P/E/G ratio of 3.38 and a beta of 3.66. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock has a fifty day moving average price of $358.95 and a 200-day moving average price of $226.07.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The company had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The firm’s quarterly revenue was up 93.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

Insiders Place Their Bets

In other Astera Labs news, Director Manuel Alba sold 8,491 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total value of $3,892,104.58. Following the transaction, the director directly owned 286,863 shares in the company, valued at $131,492,261.94. The trade was a 2.87% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director directly owned 75,688 shares of the company’s stock, valued at $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders have sold 1,676,845 shares of company stock valued at $444,928,806. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

ALAB has been the topic of several analyst reports. Evercore reaffirmed an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a research report on Tuesday, May 19th. Rothschild & Co Redburn initiated coverage on Astera Labs in a research report on Friday, May 1st. They issued a “neutral” rating and a $153.00 price target for the company. Susquehanna raised their price objective on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research note on Wednesday, May 6th. Barclays lifted their price objective on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. Finally, Bank of America upped their target price on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Twelve equities research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $282.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.